Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies.
D000328:Adult; D000917:Antibody Formation / Q000187:drug effects; D013956:Antithyroid Agents / Q000627:therapeutic use*; D001323:Autoantibodies; D005094:Exophthalmos / Q000276:immunology; D005260:Female; D006111:Graves Disease / Q000188:drug therapy / Q000276:immunology* / Q000532:radiotherapy; D006386:Hemagglutination Tests; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007166:Immunosuppressive Agents; D007456:Iodine Isotopes / Q000627:therapeutic use*; D008135:Long-Acting Thyroid Stimulator; D008297:Male; D008713:Methimazole / Q000627:therapeutic use; D008875:Middle Aged; D009230:Myxedema / Q000276:immunology; D013954:Thyroglobulin
D013956:Antithyroid Agents; D001323:Autoantibodies; D007093:Imidazoles; D007166:Immunosuppressive Agents; D007456:Iodine Isotopes; D008713:Methimazole; D013954:Thyroglobulin; D008135:Long-Acting Thyroid Stimulator